Table 4. Logistic regression analysis of risk factors associated with minor complications.
| Variable | Univariate | Multivariate | |||
|---|---|---|---|---|---|
| OR (95% CI) | P value | OR (95% CI) | P value | ||
| Age, years | 0.99 (0.94–1.03) | 0.563 | |||
| Gender (F/M) | 0.64 (0.28–1.50) | 0.308 | |||
| BMI, kg/m2 | 0.98 (0.89–1.09) | 0.760 | |||
| Smoking (yes/no) | 1.60 (0.68–3.77) | 0.282 | 1.84 (0.61–5.57) | 0.283 | |
| Hyperlipidemia (yes/no) | 2.20 (0.75–6.50) | 0.154 | 1.84 (0.46–7.33) | 0.388 | |
| CAD (yes/no) | 4.64 (1.47–14.70) | 0.009 | 6.38 (1.69–24.10) | 0.006 | |
| DM (yes/no) | 2.17 (0.58–8.20) | 0.252 | 1.39 (0.20–9.92) | 0.741 | |
| Hypertension (yes/no) | 1.62 (0.42–6.29) | 0.484 | |||
| ESRD (yes/no) | 1.63 (0.68–3.92) | 0.271 | 1.25 (0.38–4.09) | 0.713 | |
| Sheath size (7+8/5+6) | 1.25 (0.56–2.82) | 0.587 | |||
| Fontaine IV/II+III | 1.83 (0.76–4.38) | 0.177 | 1.42 (0.44–4.54) | 0.557 | |
| Intervention (PTA/stent) | 0.61 (0.23–1.62) | 0.320 | |||
| Antithrombotic drug (yes/no) | 3.97 (0.47–33.60) | 0.206 | 2.08 (0.18–24.40) | 0.561 | |
| QuikClot (yes/no) | 0.12 (0.04–0.35) | <0.001 | 0.08 (0.03–0.28) | <0.001 | |
| ACT | 1.01 (0.98–1.05) | 0.380 | |||
| Involved leg (L/R) | 0.81 (0.34–1.91) | 0.627 | |||
Multivariate analysis adjusted for age and sex. OR, odds ratio; CI, confidence interval; BMI, body mass index; CAD, coronary artery disease; DM, diabetes mellitus; ESRD, end-stage renal disease; PTA, percutaneous transluminal angioplasty; ACT, activated clotting time; L, left; R, right.